Single-cell cloning technology from iotaSciences at SLAS2021

21 January 2021
Posted in News | Tagged ,

iotaSciences, a company that develops technologies for single-cell cloning is giving exhibitor tutorials at SLAS2021 Digital. These tutorials will explore some of the key challenges of single-cell cloning for gene editing, stem cells and other applications. During the tutorials we will introduce our new cloning platform and provide customer data which demonstrates cloning efficiencies of up to 80% for hiPSCs.

The company is also offering personal online demonstrations of its technology. Contact cpilorz@iotasciences.com

Image credit: National Cancer Institute

 

Suggested Reading

Female scientist Ratio of women in UK’s R&D workforce unchanged for a decade
27 February 2023
Microglia Poster: Accelerated production of functional microglia
5 July 2023

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free